108412008: Rizatriptan benzoate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Substance with serotonin receptor agonist mechanism of action (substance)\Serotonin 5-HT1 receptor agonist\Rizatriptan benzoate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Serotonin 5-HT1 receptor agonist\Rizatriptan benzoate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole (substance)\Substance with triazole structure (substance)\Rizatriptan benzoate

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole (substance)\Substance with triazole structure (substance)\Rizatriptan benzoate
\Organic compound\Organic nitrogen compound\Azole (substance)\Substance with triazole structure (substance)\Rizatriptan benzoate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

326408015 Rizatriptan benzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

600461015 Rizatriptan benzoate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3145961000005113 rizatriptanbenzoat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rizatriptan benzoate	Is a	Product containing rizatriptan (medicinal product)	false	Inferred relationship	Some
Rizatriptan benzoate	Is a	Serotonin 5-HT1 receptor agonist	true	Inferred relationship	Some
Rizatriptan benzoate	Is a	Rizatriptan (substance)	false	Inferred relationship	Some
Rizatriptan benzoate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition)	true	Inferred relationship	Some
Rizatriptan benzoate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Rizatriptan (substance)	true	Inferred relationship	Some
Rizatriptan benzoate	Is a	Triazole derivative	false	Inferred relationship	Some
Rizatriptan benzoate	Is a	Substance with triazole structure (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Rizatriptan 5 mg smeltetablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
Rizatriptan (as rizatriptan benzoate) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
rizatriptan smeltetablet 10 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
Rizatriptan (as rizatriptan benzoate) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some	1
Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some	1
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
Rizatriptan 10mg conventional release oral lyophilisate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rizatriptan benzoate	Inferred relationship	Some
Rizatriptan (as rizatriptan benzoate) 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rizatriptan benzoate	Inferred relationship	Some	1
Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rizatriptan benzoate	Inferred relationship	Some	1
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rizatriptan benzoate	Inferred relationship	Some	1
Rizatriptan (as rizatriptan benzoate) 10 mg oral lyophilisate	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rizatriptan benzoate	Inferred relationship	Some	1

This concept is not in any reference sets